Other Assets, Current in USD of Aptevo Therapeutics Inc. from Q4 2016 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Aptevo Therapeutics Inc. quarterly Other Assets, Current history and change rate from Q4 2016 to Q3 2025.
  • Aptevo Therapeutics Inc. Other Assets, Current for the quarter ending 30 Sep 2025 was $77K, a 87.7% decline year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Change (%)

Aptevo Therapeutics Inc. Quarterly Other Assets, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $77K -$547K -87.7% 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 $82K -$633K -88.5% 30 Jun 2025 10-Q 11 Aug 2025
Q1 2025 $120K -$571K -82.6% 31 Mar 2025 10-Q 15 May 2025
Q4 2024 $256K -$433K -62.8% 31 Dec 2024 10-Q 06 Nov 2025
Q3 2024 $624K -$25K -3.85% 30 Sep 2024 10-Q 07 Nov 2024
Q2 2024 $715K -$49K -6.41% 30 Jun 2024 10-Q 08 Aug 2024
Q1 2024 $691K -$891K -56.3% 31 Mar 2024 10-Q 08 May 2024
Q4 2023 $689K -$55K -7.39% 31 Dec 2023 10-K 14 Feb 2025
Q3 2023 $649K -$9K -1.37% 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 $764K -$4K -0.52% 30 Jun 2023 10-Q 10 Aug 2023
Q1 2023 $1.58M +$705K +80.4% 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $744K -$36K -4.62% 31 Dec 2022 10-K 05 Mar 2024
Q3 2022 $658K +$649K +7211% 30 Sep 2022 10-Q 10 Nov 2022
Q2 2022 $768K +$702K +1064% 30 Jun 2022 10-Q 11 Aug 2022
Q1 2022 $877K +$794K +957% 31 Mar 2022 10-Q 12 May 2022
Q4 2021 $780K +$647K +486% 31 Dec 2021 10-K 30 Mar 2023
Q3 2021 $9K -$197K -95.6% 30 Sep 2021 10-Q 12 Nov 2021
Q2 2021 $66K -$32K -32.7% 30 Jun 2021 10-Q 12 Aug 2021
Q1 2021 $83K -$1.14M -93.2% 31 Mar 2021 10-Q 11 May 2021
Q4 2020 $133K -$27K -16.9% 31 Dec 2020 10-K 24 Mar 2022
Q3 2020 $206K -$1.29M -86.2% 30 Sep 2020 10-Q 10 Nov 2020
Q2 2020 $98K -$3.07M -96.9% 30 Jun 2020 10-Q 14 Aug 2020
Q1 2020 $1.22M -$2.34M -65.6% 31 Mar 2020 10-Q 13 May 2020
Q4 2019 $160K -$3.98M -96.1% 31 Dec 2019 10-K 31 Mar 2021
Q3 2019 $1.49M -$5.5M -78.7% 30 Sep 2019 10-Q 07 Nov 2019
Q2 2019 $3.17M -$3.97M -55.6% 30 Jun 2019 10-Q 09 Aug 2019
Q1 2019 $3.56M -$3.07M -46.3% 31 Mar 2019 10-Q 09 May 2019
Q4 2018 $4.14M -$2.57M -38.3% 31 Dec 2018 10-K 25 Mar 2020
Q3 2018 $6.99M 30 Sep 2018 10-Q 14 Nov 2018
Q2 2018 $7.14M 30 Jun 2018 10-Q 09 Aug 2018
Q1 2018 $6.63M 31 Mar 2018 10-Q 10 May 2018
Q4 2017 $6.71M +$4.68M +231% 31 Dec 2017 10-K 18 Mar 2019
Q4 2016 $2.03M 31 Dec 2016 10-K 13 Mar 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.